Oncogenic HPV among HIV infected female population in West Bengal, India

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Sarkar, Kamalesh ^a   Pal, Reshmi ^a   Bal, Baishali ^a   Saha, Bibhuti ^b   Bhattacharya, Subhasish ^c   Sengupta, Sharmila ^d   Mazumdar, Partha P ^d   Chakraborti, Shekhar ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CELL; CERVICAL CELL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INDIA; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREVALENCE; SEXUAL INTERCOURSE; UTERINE CERVIX; ADOLESCENT; AGE DISTRIBUTION; GENETICS; ISOLATION AND PURIFICATION; VIROLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INDIA; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; YOUNG ADULT;

EID: 79953072787     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-72     Document Type: Article

References (24)

1. Government of India-World Health Organization Collaborative Programme Guidelines for Cervical Cancer Screening Programme 2006, Chandigarh Postgraduate Institute of Medical Education and Research, Government of India-World Health Organization Collaborative Programme.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCON 2000: cancer incidence, mortality and prevalence worldwide. version 1.0; IARC Cancer base No. 5 2000, Lyon, France: IARC Press.
3. World Health Organization Human Papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Geneva 2007, World Health Organization.
4. AIDS Epidemic Update available through. , http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp
5. Strickler HD, Burk RD, Fazzari M, nastos K, Minkoff H, Massad LS. Natural History and Possible Reactivation of Human Paillomavirus in Human Immunodeficiency Virus-Positive Women. J Natl Cancer Inst 2005, 97:577-586. 10.1093/jnci/dji073, 15840880.
6. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995, 85(5 Pt 1):680. 10.1016/0029-7844(95)00025-M, 7724095.
7. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl 1):S1-S15.
8. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819. 10.1001/jama.297.8.813, 17327523.
9. Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine 2008, 26(Suppl 12):M43-52. 10.1016/j.vaccine.2008.05.005, 18945413.
10. Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004, 111:278-285.
11. Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E. Infection with Human Papillomavirus and HIV among Young Women in Kampala, Uganda. J Infect Dis 2008, 197:555-562. 10.1086/526792, 18237268.
12. Joshi SN, Gopalkrishna V, Kumar BK, Dutta S, Nyaynirgune P, Thakar M, Tripathy S, Mehendale S, Paranjape R. Cervical Squamous Intra-Epithelial Changes and Human Papillomavirus Infection in Women Infected With Human Immunodeficiency Virus in Pune, India. J Med Virol 2005, 76:470-475. 10.1002/jmv.20385, 15977244.
13. Peedicayil A, Thiyagarajan K, Gnanamony M, Pulimood SA, Jeyaseelan V, Kannangai R, Lionel J, Abraham OC, Abraham P. Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India. J Low Genit Tract Dis 2009,
14. Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, Lewis DA, Williamson AL, Allan B, Williams S, Rinas A, Levin S, Smith JS. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control 2010, 21(3):433-443. 10.1007/s10552-009-9475-z, 2835728, 19949850.
15. Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, Rwamwejo J, Vuolo M, Cohen M, Castle PE. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis 2009, 199(12):1851-1861. 10.1086/599123, 2814215, 19435429.
16. Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol 2007, 79(6):758-765. 10.1002/jmv.20817, 2846524, 17457908.
17. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, Van den Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000, 27(8):438-445. 10.1097/00007435-200009000-00003, 10987448.
18. Sarkar K, Bhattacharya S, Bhattacharya S, Chatterjee S, Mallick AH, Chakraborti S, Chatterjee D, Bal B. Oncogenic human papillomavirus and cervical pre-cancerous lesions in brothel-based sex workers in India. J Infect Public Health 2008, 1(2):121-128. 10.1016/j.jiph.2008.09.001, 20701853.
19. Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJ, Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer 2005, 92(3):601-606. 2362069, 15668709.
20. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998. 10.1016/S0140-6736(05)67069-9, 16168781.
21. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM, Chauhan MK, Desai S, Fontaniere B, Frappart L, Kothari A, Lucas E, Panse N. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005, 116(4):617-623. 10.1002/ijc.21050, 15818610.
22. Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, Dinshaw K, Mandal R, Amin G, Goswami S, Pal S, Patil S, Dhakad N, Frappart L, Fontaniere B. Accuracy of human papilloma virus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004, 112(2):341-347. 10.1002/ijc.20396, 15352050.
23. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, Rao BN, Devi RR, Gravitt PE, Ramakrishna G. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005, 5:116. 10.1186/1471-2334-5-116, 1345691, 16371167.
24. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol 2010, 116(3):572-577. 10.1016/j.ygyno.2009.10.058, 19906410.